X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1182) 1182
Publication (107) 107
Newsletter (24) 24
Book Review (12) 12
Magazine Article (8) 8
Book Chapter (5) 5
Conference Proceeding (4) 4
Book / eBook (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (954) 954
primaquine - therapeutic use (738) 738
antimalarials - therapeutic use (604) 604
primaquine (541) 541
male (531) 531
malaria (506) 506
index medicus (433) 433
female (426) 426
adult (418) 418
animals (415) 415
chloroquine - therapeutic use (381) 381
malaria - drug therapy (341) 341
malaria, vivax - drug therapy (311) 311
tropical medicine (304) 304
infectious diseases (270) 270
parasitic diseases (260) 260
plasmodium vivax (246) 246
adolescent (232) 232
middle aged (232) 232
parasitology (229) 229
child (219) 219
drug therapy, combination (194) 194
chloroquine (193) 193
research (175) 175
primaquine - administration & dosage (170) 170
plasmodium falciparum (163) 163
drug resistance (157) 157
antimalarials - administration & dosage (155) 155
malaria - prevention & control (148) 148
child, preschool (146) 146
treatment outcome (145) 145
malaria, falciparum - drug therapy (143) 143
infections (142) 142
recurrence (139) 139
plasmodium vivax - drug effects (135) 135
parasites (132) 132
public, environmental & occupational health (132) 132
plasmodium falciparum - drug effects (130) 130
young adult (118) 118
drug therapy (114) 114
medicine, general & internal (114) 114
primaquine - adverse effects (111) 111
antimalarials - pharmacology (110) 110
pharmacology & pharmacy (110) 110
aged (107) 107
health aspects (107) 107
artemisinins - therapeutic use (105) 105
antimalarials - adverse effects (103) 103
malaria, vivax - epidemiology (101) 101
antimalarials (99) 99
microbiology (99) 99
primaquine - pharmacology (99) 99
drugs (91) 91
infant (91) 91
malaria, vivax - parasitology (90) 90
travel (90) 90
falciparum (89) 89
mice (89) 89
drug combinations (88) 88
infectious and parasitic diseases (88) 88
malaria, vivax - prevention & control (86) 86
efficacy (84) 84
vector-borne diseases (84) 84
arctic medicine. tropical medicine (83) 83
dosage and administration (79) 79
medicine (78) 78
pyrimethamine - therapeutic use (78) 78
prophylaxis (77) 77
public health (77) 77
resistance (77) 77
drug dosages (76) 76
quinine - therapeutic use (76) 76
transmission (76) 76
prevention (75) 75
research article (75) 75
care and treatment (74) 74
vivax malaria (74) 74
relapse (71) 71
malaria - parasitology (69) 69
time factors (69) 69
malaria - epidemiology (68) 68
plasmodium vivax - isolation & purification (67) 67
blood (66) 66
thailand (65) 65
mefloquine - therapeutic use (63) 63
immunology (62) 62
analysis (61) 61
drug resistance, microbial (61) 61
children (60) 60
chloroquine - administration & dosage (59) 59
erythrocytes (59) 59
malaria, falciparum - prevention & control (59) 59
parasitemia - drug therapy (59) 59
therapy (59) 59
aminoquinolines - therapeutic use (58) 58
falciparum-malaria (58) 58
medical research (57) 57
proguanil - therapeutic use (57) 57
chloroquine - pharmacology (56) 56
drug administration schedule (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1113) 1113
Spanish (20) 20
Chinese (17) 17
German (17) 17
French (11) 11
Portuguese (9) 9
Japanese (7) 7
Russian (7) 7
Italian (4) 4
Danish (2) 2
Dutch (2) 2
Korean (2) 2
Turkish (2) 2
Norwegian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Malaria Journal, ISSN 1475-2875, 2010, Volume 9, Issue 1, pp. 136 - 136
BACKGROUND: There is renewed acknowledgement that targeting gametocytes is essential for malaria control and elimination efforts. Simple mathematical models... 
INFECTIOUS DISEASES | TRANSMISSION-BLOCKING VACCINES | COMBINATION THERAPY | TROPICAL MEDICINE | MALARIA TRANSMISSION | SEASONAL TRANSMISSION | ANTIMALARIAL-DRUGS | STAGE PARASITES | PRIMAQUINE | ARTEMISININ | SEQUENCE-BASED AMPLIFICATION | ARTESUNATE | PARASITOLOGY | Self-Sustained Sequence Replication - methods | Tanzania - epidemiology | Ethanolamines - pharmacology | Prevalence | Kenya - epidemiology | Germ Cells - drug effects | Humans | Fluorenes - therapeutic use | Child, Preschool | Infant | Male | Fluorenes - pharmacology | Parasitemia - drug therapy | Plasmodium falciparum - drug effects | Amodiaquine - pharmacology | Artemisinins - pharmacology | Time Factors | Sulfadoxine - therapeutic use | Plasmodium falciparum - isolation & purification | Malaria, Falciparum - epidemiology | Female | Amodiaquine - therapeutic use | Drug Therapy, Combination | Parasitemia - epidemiology | Child | Infant, Newborn | Pyrimethamine - therapeutic use | Malaria, Falciparum - drug therapy | Carrier State - parasitology | Treatment Outcome | Antimalarials - therapeutic use | Clinical Trials as Topic | Antimalarials - pharmacology | Malaria, Falciparum - parasitology | Artemisinins - therapeutic use | Models, Biological | Primaquine - therapeutic use | Adolescent | Parasitemia - parasitology | Ethanolamines - therapeutic use | Primaquine - pharmacology | Plasmodium falciparum - growth & development | Drug Combinations | Plasmodium falciparum | Control | Malaria | Physiological aspects | Gametocytes | Research | Drug therapy | Health aspects | Drugs | Therapy | Methodology | Primaquine | Artemisinin | Erythrocytes | Clinical trials | Infections | Parasites | Blood | Reduction | Artesunate | Peripheral blood | Mathematical models | Drug dosages | Sequencing | Public health | Vector-borne diseases | Medical research | Human diseases | Nucleotide sequence | Pyrimethamine | Duration | Nucleic acids | Studies | Mosquitoes | Amodiaquine | Artemether | Detection | Circulation
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2018, Volume 2018, Issue 2, p. CD008152
Background The 8-aminoquinoline (8AQ) drugs act on Plasmodium falciparum gametocytes, which transmit malaria from infected people to mosquitoes. In 2012, the... 
45 MG PRIMAQUINE | ARTEMETHER-LUMEFANTRINE | SULFADOXINE-PYRIMETHAMINE | Artemisinins [administration & dosage; therapeutic use] | Quinine [therapeutic use] | Plasmodium falciparum [drug effects] | Malaria, Falciparum [parasitology; prevention & control; transmission] | LOW-DOSE PRIMAQUINE | GAMETOCYTOCIDAL ACTIVITY | Primaquine [administration & dosage] | Glucosephosphate Dehydrogenase Deficiency [diagnosis] | SPORONTOCIDAL TREATMENT | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | Sulfadoxine [administration & dosage] | MALARIA CONTROL | DIHYDROARTEMISININ-PIPERAQUINE | THERAPEUTIC-EFFICACY | Pyrimethamine [administration & dosage] | ARTESUNATE-MEFLOQUINE | Antimalarials [administration & dosage] | Mefloquine [therapeutic use] | Drug Combinations | Chloroquine [therapeutic use] | Malaria, Falciparum - prevention & control | Humans | Artemisinins - administration & dosage | Sulfadoxine - administration & dosage | Chloroquine - therapeutic use | Plasmodium falciparum - drug effects | Primaquine - administration & dosage | Glucosephosphate Dehydrogenase Deficiency - diagnosis | Malaria, Falciparum - parasitology | Malaria, Falciparum - transmission | Quinine - therapeutic use | Primaquine - analogs & derivatives | Artemisinins - therapeutic use | Mefloquine - therapeutic use | Antimalarials - administration & dosage | Pyrimethamine - administration & dosage | Time Factors | Mefloquine - administration & dosage | Non-Randomized Controlled Trials as Topic | Adult | Chloroquine - administration & dosage | Child
Journal Article
Journal Article